Carl L Gordon Buys $745K of Electra Therapeutics Inc (ETRA) — SEC Form 4, Nov 11, 2026
Equity Position
5.26M sh
5,163,162 → 5,255,278
Equity Change
+1.8%
shares held after vs before
Insider Cluster
4 buying
within 30 days — view cluster
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Carl L Gordon CIK 0001282930 |
Director
10% Owner
|
Carl L Gordon at Electra Therapeutics Inc
Full insider history
Bought (12 mo)
$24,349,642
Sold (12 mo)
—
More from this insider at Electra Therapeutics Inc
| 2026-11-05 | Buy | +$3,605,116 | View |
| 2026-09-23 | Buy | +$19,999,995 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1F3 | 2026-11-06 | P - Purchase | 9,816 A | $7.85 | +$77,056 | 5,230,578 | Indirect See footnotes |
| Common StockF2F3 | 2026-11-06 | P - Purchase | 39,600 A | $7.85 | +$310,860 | 2,176,579 | Indirect See footnotes |
| Common StockF1F3 | 2026-11-09 | P - Purchase | 4,000 A | $8.24 | +$32,960 | 5,234,578 | Indirect See footnotes |
| Common StockF2F3 | 2026-11-09 | P - Purchase | 16,000 A | $8.24 | +$131,840 | 2,192,579 | Indirect See footnotes |
| Common StockF1F3 | 2026-11-10 | P - Purchase | 20,700 A | $8.45 | +$174,915 | 5,255,278 | Indirect See footnotes |
| Common StockF2F3 | 2026-11-10 | P - Purchase | 2,000 A | $8.45 | +$16,900 | 2,194,579 | Indirect See footnotes |
Footnotes (3)
- F1
- These securities are held directly by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("GP VII") is the general partner of OPI VII. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VII. By virtue of such relationships, GP VII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI VII. Show more
- F2
- These securities are held directly by OrbiMed Genesis Master Fund, L.P. ("OrbiMed Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of OrbiMed Genesis. OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OrbiMed Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OrbiMed Genesis. Show more
- F3
- Each of the Reporting Person, OrbiMed Advisors, GP VII and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. Show more
Related filings at Electra Therapeutics Inc
5%+ Holders · 13D/G
4 filers
-
Redmile Group, Llc 8.7%
-
Orbimed Advisors Llc 11.0%
Other insiders at Electra Therapeutics Inc
GET /v1/forms/4/0000947871-26-001011
API docs
View Original SEC Filing